Survival after bilateral breast cancer: results from a population-based study
- 21 December 2006
- journal article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 105 (3), 347-357
- https://doi.org/10.1007/s10549-006-9455-x
Abstract
Controversy exists on the impact of bilaterality of breast cancer on survival. We used population-based data to compare survival of women with unilateral versus bilateral breast cancer. At the Geneva cancer registry, we identified all 7,912 women diagnosed with invasive breast cancer between 1970 and 2002. Breast cancers were categorized as unilateral, synchronous bilateral (contralateral tumour diagnosed within six months after the first tumour) and metachronous bilateral (contralateral tumour diagnosed over six months after the first tumour). With multivariate modelling we compared characteristics and survival between women with unilateral and bilateral disease. Patients with synchronous bilateral tumours (n = 155, 2.0%) had more often lobular histology and less frequently stage I disease than women with unilateral disease. Women with metachronous breast cancer (n = 219, 2.8%) received less often chemotherapy or hormone therapy for their first tumours. Ten-year disease-specific survival was similar (66%) after unilateral and metachronous bilateral breast cancer, but worse after synchronous bilateral cancer (51%). After adjustment, breast cancer mortality risks were not significantly increased for women with either synchronous or metachronous bilateral disease (Hazard ratios 1.1 (0.8–1.5) and 0.8 (0.5–1.4), respectively). This large population-based study indicates that bilaterality of breast cancer is not associated with impaired survival.Keywords
This publication has 29 references indexed in Scilit:
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institutionCancer, 2004
- Contralateral Breast Cancer: Factors Associated with Stage and Size at PresentationThe Breast Journal, 2004
- Referral for cancer genetics consultation: a review and compilation of risk assessment criteriaJournal of Medical Genetics, 2004
- Bilateral synchronous breast cancer: A population-based study of characteristics, method of detection, and survivalSurgery, 2003
- A case-control study of unilateral and bilateral breast carcinoma patientsCancer, 2001
- Clinical and histological predictors of contralateral breast cancerEuropean Journal of Surgical Oncology, 1999
- BRCA1 and BRCA2 founder mutations in patients with bilateral breast cancerEuropean Journal of Human Genetics, 1999
- Bilateral Breast Carcinoma Versus Unilateral DiseaseAmerican Journal of Clinical Oncology, 1997
- Bilateral Breast Cancer Risk Reduction by Contralateral BiopsyAnnals of Surgery, 1985